TABLE OF CONTENTS I
LIST OF FIGURES XIII
LIST OF CHARTS XLII
EXECUTIVE SUMMARY 1
EUROPEAN CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 9
PROCEDURE NUMBERS 12
MARKETS INCLUDED 13
KEY REPORT UPDATES 15
VERSION HISTORY 15
RESEARCH METHODOLOGY 16
Step 1: Project Initiation & Team Selection 16
Step 2: Prepare Data Systems and Perform Secondary Research 19
Step 3: Preparation for Interviews & Questionnaire Design 21
Step 4: Performing Primary Research 22
Step 5: Research Analysis: Establishing Baseline Estimates 24
Step 6: Market Forecast and Analysis 25
Step 7: Identify Strategic Opportunities 27
Step 8: Final Review and Market Release 28
Step 9: Customer Feedback and Market Monitoring 29
DISEASE OVERVIEW 30
2.1 INTRODUCTION 30
2.2 TYPES OF ARRHYTHMIAS 31
2.2.11 Atrial Fibrillation 31
2.2.12 Bradycardia 32
2.2.13 Conduction Disorders 32
2.2.13.1 Bundle Branch Block 32
2.2.13.2 Heart Block 33
2.2.13.3 Long QT Syndrome (LQTS) 34
2.2.14 Premature Contractions: PACs and PVCs 34
2.2.15 Tachycardia 35
2.2.16 Ventricular Fibrillation 35
2.2.17 Other Rhythm Disorders 36
2.2.17.1 Adams-Stokes Disease 36
2.2.17.2 Atrial Flutter 36
2.2.17.3 Sick Sinus syndrome 37
2.2.17.4 Sinus Arrhythmia 37
2.2.17.5 Wolff-Parkinson-White Syndrome (WPW) 37
2.2.18 Types of Arrhythmia in Children 37
2.3 HEART FAILURE 37
2.4 CARDIAC ARREST 38
2.5 PATIENT DEMOGRAPHICS 40
2.5.11 Atrial Fibrillation 40
2.5.12 Bradycardia 40
2.5.13 Conduction Disorders 41
2.5.14 Premature Contractions – PACs and PVCs 42
2.5.15 Tachycardia 43
2.5.16 Ventricular Fibrillation 43
2.5.17 Other Rhythm Disorders 44
PRODUCT ASSESSMENT 45
3.1 INTRODUCTION 45
3.2 PRODUCT PORTFOLIOS 45
3.2.1 Pacemakers 45
3.2.2 Implantable Cardioverter Defibrillators (ICDs) 48
3.2.3 Cardiac Resynchronization Therapy (CRT) Devices 50
3.2.4 Cardiac Leads 52
3.2.5 External Defibrillators 54
3.2.6 Lab Systems 56
3.2.6.1 Introduction 56
3.2.6.2 3D Mapping Systems 56
3.2.6.3 EP Recording Systems 57
3.2.6.4 Remote Steering Systems 58
3.2.6.5 RF Ablation Generator 58
3.2.6.6 ICE Systems 58
3.2.6.7 Product Matrix for Lab Systems: Core Companies 60
3.2.7 Diagnostic EP Catheters 61
3.2.7.1 Introduction 61
3.2.7.2 Diagnostic EP Catheters 61
3.2.7.3 ICE Catheters 62
3.2.8 Cardiac Ablation Catheters 64
3.2.8.1 Introduction 64
3.2.8.2 RF Ablation Catheters 65
3.2.8.3 Alternative Energy Catheters 66
3.2.8.4 High Intensity Focused Ultrasound 66
3.3 REGULATORY ISSUES AND RECALLS 69
3.3.1 Abbott 69
3.3.1.1 Pacemakers 69
3.3.1.2 Implantable Cardioverter Defibrillators (ICDs) 70
3.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices 71
3.3.1.4 Cardiac Leads 72
3.3.1.5 EP Lab Devices 72
3.3.1.6 Cardiac Ablation Catheter 73
3.3.2 Biosense Webster 74
3.3.2.1 EP Lab Devices 74
3.3.3 Boston Scientific 75
3.3.3.1 Pacemakers 75
3.3.3.2 Implantable Cardioverter Defibrillators (ICDs) 81
3.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices 82
3.3.3.4 Cardiac Leads 85
3.3.3.5 EP Lab Devices 85
3.3.3.6 RF Ablation Catheter 86
3.3.4 Cardiac Science 87
3.3.4.1 Automated External Defibrillator (AED) 87
3.3.5 Medtronic 88
3.3.5.1 Pacemakers 88
3.3.5.2 Implantable Cardioverter Defibrillators (ICDs) 89
3.3.5.3 Cardiac Resynchronization Therapy (CRT) Devices 92
3.3.5.4 Cardiac Leads 95
3.3.5.5 EP Lab Devices 95
3.3.6 MicroPort 96
3.3.6.1 Implantable Cardioverter Defibrillators (ICDs) 96
3.3.6.2 Cardiac Resynchronization Therapy (CRT) Devices 98
3.3.7 Philips Healthcare 100
3.3.7.1 Automated External Defibrillator (AED) 100
3.3.8 Stryker Sustainability Solutions 102
3.3.8.1 Diagnostic EP Catheters 102
3.3.9 ZOLL 104
3.3.9.1 Automated External Defibrillator (AED) 104
3.3.9.2 Wearable Cardioverter Defibrillator (WCD) 104
3.4 CLINICAL TRIALS 105
3.4.1 Pacemakers 105
3.4.2 Implantable Cardioverter Defibrillators (ICDs) 109
3.4.3 Cardiac Resynchronization Therapy (CRT) Devices 112
3.4.4 Cardiac Leads 117
3.4.5 External Defibrillators 123
3.4.6 Lab Systems 124
3.4.6.1 3D Mapping Systems 124
3.4.6.2 EP Recording Systems 126
3.4.6.3 RF Ablation Generators 127
3.4.6.4 ICE Systems 128
3.4.7 Diagnostic EP Catheters 130
3.4.7.1 Diagnostic Catheter 130
3.4.8 Cardiac Ablation Catheter 132
3.4.8.1 RF Ablation Catheters 132
3.4.8.2 Cryoablation Catheters 135
3.4.8.3 Laser Ablation Catheters 141
EUROPEAN CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW 143
4.1 INTRODUCTION 143
4.2 CURRENCY EXCHANGE RATE 144
4.3 MARKET OVERVIEW 145
4.4 TREND ANALYSIS BY SEGMENT 153
4.5 DRIVERS AND LIMITERS 157
4.5.1 Market Drivers 157
4.5.2 Market Limiters 158
4.6 COMPETITIVE MARKET SHARE ANALYSIS 161
4.7 MERGERS AND ACQUISITIONS 166
4.8 COMPANY PROFILES 167
4.8.1 Abbott 167
4.8.2 Biosense Webster 168
4.8.3 Biotronik 169
4.8.4 Boston Scientific 170
4.8.5 Cardiac Science 172
4.8.6 GE Healthcare 173
4.8.7 Medtronic 174
4.8.8 MicroPort 175
4.8.9 ZOLL 177
4.9 SWOT ANALYSIS 178
4.9.1 Abbott 178
4.9.2 Biosense Webster 180
4.9.3 Biotronik 181
4.9.4 Boston Scientific 182
4.9.5 Cardiac Science 183
4.9.6 GE Healthcare 184
4.9.7 Medtronic 185
4.9.8 MicroPort 186
4.9.9 ZOLL 188
COUNTRY PROFILES 189
5.1 INTRODUCTION 189
5.1.1 Population 189
5.1.2 GDP Per Capita 189
5.1.3 Price Index 189
5.2 GERMANY 190
5.3 FRANCE 191
5.4 UNITED KINGDOM 192
5.5 ITALY 193
5.6 SPAIN 194
PROCEDURE NUMBERS 195
6.1 INTRODUCTION 195
6.2 PROCEDURES 196
6.2.1 Total Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures 196
 
PACEMAKER MARKET 199
7.1 INTRODUCTION 199
7.1.1 Single and Dual-Chamber Devices 199
7.1.2 MRI-Compatible Pacemaker 200
7.1.3 Leadless Pacemaker 200
7.1.4 Initial Placement and Replacement of Pacemakers 201
7.2 MARKET OVERVIEW 202
7.3 MARKET ANALYSIS AND FORECAST 207
7.3.1 Total Pacemaker Market 207
7.3.2 Total Single-Chamber Pacemaker Market 214
7.3.2.1.1 Initial Placement Single-Chamber Pacemaker Market 225
7.3.2.1.2 Replacement Single-Chamber Pacemaker Market 232
7.3.3 Total Dual-Chamber Pacemaker Market 239
7.3.3.1.1 Initial Placement Dual-Chamber Pacemaker Market 250
7.3.3.1.2 Replacement Dual-Chamber Pacemaker Market 257
7.3.4 Leadless Pacemaker Market 264
7.4 PRICE ANALYSIS 272
7.5 DRIVERS AND LIMITERS 273
7.5.1 Market Drivers 273
7.5.2 Market Limiters 274
7.6 COMPETITIVE MARKET SHARE ANALYSIS 276
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET 283
8.1 INTRODUCTION 283
8.1.1 Cardiac Resynchronization Therapy-Defibrillators 284
8.2 MARKET OVERVIEW 285
8.3 MARKET ANALYSIS AND FORECAST 290
8.3.1 Total ICD Market 290
8.3.2 Total Single-Chamber ICD Market 297
8.3.2.1.1 Initial Placement Single-Chamber ICD Market 308
8.3.2.1.2 Replacement Single-Chamber ICD Market 315
8.3.3 Total Dual-Chamber ICD Market 322
8.3.3.1.1 Initial Placement Dual-Chamber ICD Market 333
8.3.3.1.2 Replacement Dual-Chamber ICD Market 340
8.3.4 S-ICD Market 347
8.4 DRIVERS AND LIMITERS 355
8.4.1 Market Drivers 355
8.4.2 Market Limiters 356
8.5 COMPETITIVE MARKET SHARE ANALYSIS 358
CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET 364
9.1 INTRODUCTION 364
9.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 364
9.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 364
9.2 MARKET OVERVIEW 365
9.3 MARKET ANALYSIS AND FORECAST 370
9.3.1 Total CRT Market 370
9.3.2 Total CRT-P Market 377
9.3.2.1.1 Initial Placement CRT-P Market 387
9.3.2.1.2 Replacement CRT-P Market 394
9.3.3 Total CRT-D Market 401
9.3.3.1.1 Initial Placement CRT-D Market 411
9.3.3.1.2 Replacement CRT-D Market 418
9.4 DRIVERS AND LIMITERS 425
9.4.1 Market Drivers 425
9.4.2 Market Limiters 426
9.5 COMPETITIVE MARKET SHARE ANALYSIS 429
CARDIAC LEADS MARKET 435
10.1 INTRODUCTION 435
10.1.1 Replacement of Leads 436
10.2 MARKET OVERVIEW 437
10.3 MARKET ANALYSIS AND FORECAST 442
10.3.1 Total Cardiac Leads Market 442
10.3.2 Pacing Lead Market 449
10.3.3 Defibrillation Lead Market 456
10.3.4 LV Lead Market 463
10.4 DRIVERS AND LIMITERS 470
10.4.1 Market Drivers 470
10.4.2 Market Limiters 471
10.5 COMPETITIVE MARKET SHARE ANALYSIS 473
LAB SYSTEMS MARKET 480
11.1 INTRODUCTION 480
11.1.1 3D Mapping Systems 480
11.1.2 EP Recording Systems 481
11.1.3 Remote Steering Systems 481
11.1.4 RF Ablation Generator 481
11.1.5 ICE System 482
11.2 MARKET OVERVIEW 483
11.3 MARKET ANALYSIS AND FORECAST 488
11.3.1 3D Mapping Market 488
11.3.2 EP Recording Market 495
11.3.3 RF Ablation Generator Market 502
11.3.4 Remote Steering System Market 509
11.4 DRIVERS AND LIMITERS 516
11.4.1 Market Drivers 516
11.4.2 Market Limiters 517
11.5 COMPETITIVE MARKET SHARE ANALYSIS 519
DIAGNOSTIC ELECTROPHYSIOLOGY CATHETER MARKET 523
12.1 INTRODUCTION 523
12.1.1 Diagnostic Electrophysiology Catheters 523
12.1.2 Reprocessed Catheters 524
12.1.3 Intracardiac Echocardiography 524
12.2 MARKET OVERVIEW 525
12.3 MARKET ANALYSIS AND FORECAST 530
12.3.1 Total Diagnostic Electrophysiology Catheter Market 530
12.3.2 Total EP Conventional Catheter Market 538
12.3.2.1.1 Fixed EP Catheter Market 548
12.3.2.1.2 Steerable EP Catheter Market 555
12.3.3 EP Advanced Catheter Market 562
12.3.4 ICE Diagnostic System Market 569
12.4 DRIVERS AND LIMITERS 577
12.4.1 Market Drivers 577
12.4.2 Market Limiters 578
12.5 COMPETITIVE MARKET SHARE ANALYSIS 581
CARDIAC ABLATION CATHETER MARKET 585
13.1 INTRODUCTION 585
13.2 MARKET OVERVIEW 587
13.3 MARKET ANALYSIS AND FORECAST 592
13.3.1 Total Cardiac Ablation Catheter Market 592
13.3.2 Total RF Ablation Catheter Market 599
13.3.2.1.1 Irrigated RF Ablation Catheter Market 610
13.3.2.1.2 Non-Irrigated RF Ablation Catheter Market 617
13.3.3 Cryoablation Catheter Market 624
13.4 DRIVERS AND LIMITERS 631
13.4.1 Market Drivers 631
13.4.2 Market Limiters 632
13.5 COMPETITIVE MARKET SHARE ANALYSIS 633
 
APPENDIX I: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) GENERATOR MARKET 638
14.1 INTRODUCTION 638
14.2 MARKET ANALYSIS AND FORECAST 639
14.3 DRIVERS AND LIMITERS 646
14.3.1 Market Drivers 646
14.3.2 Market Limiters 647
14.4 COMPETITIVE MARKET SHARE ANALYSIS 649
APPENDIX II: CRYOABLATION GENERATOR MARKET 652
15.1 INTRODUCTION 652
15.2 MARKET ANALYSIS AND FORECAST 653
15.3 DRIVERS AND LIMITERS 660
15.3.1 Market Drivers 660
15.3.2 Market Limiters 661
15.4 COMPETITIVE MARKET SHARE ANALYSIS 663
APPENDIX III: ELECTROCARDIOGRAPHY MONITORING MARKET 664
16.1 INTRODUCTION 664
16.1.1 Holter Monitoring 665
16.1.2 Stress Testing 665
16.2 MARKET OVERVIEW 666
16.3 MARKET ANALYSIS AND FORECAST 671
16.3.1 Total Resting ECG Device Market 671
16.3.1.1.1 Hospital-Based Resting ECG Device Market 681
16.3.1.1.2 Office-Based Resting ECG Device Market 688
16.3.2 Total Stress Testing Device Market 695
16.3.2.1.1 Hospital-Based Stress Testing Device Market 706
16.3.2.1.2 Office-Based Stress Testing Device Market 713
16.3.3 Total Holter Monitoring Recorder Market 720
16.3.3.1.1 Hospital-Based Holter Monitoring Recorder Market 731
16.3.3.1.2 Office-Based Holter Monitoring Recorder Market 738
16.3.3.1.3 IDTF Holter Monitoring Recorder Market 745
16.4 DRIVERS AND LIMITERS 752
16.4.1 Market Drivers 752
16.4.2 Market Limiters 753
16.5 COMPETITIVE MARKET SHARE ANALYSIS 756
APPENDIX IV: EXTERNAL DIFIBRILLATOR MARKET 760
17.1 INTRODUCTION 760
17.1.1 Automated External Defibrillator 760
17.1.2 Wearable Cardioverter Defibrillator 760
17.2 MARKET OVERVIEW 762
17.3 MARKET ANALYSIS AND FORECAST 767
17.3.1 Total External Defibrillator Market 767
17.3.2 Automated External Defibrillator Market 775
17.3.3 Wearable Cardioverter Defibrillator Market 782
17.4 DRIVERS AND LIMITERS 789
17.4.1 Market Drivers 789
17.4.2 Market Limiters 790
17.5 COMPETITIVE MARKET SHARE ANALYSIS 792
ABBREVIATIONS 795

The "Cardiac Rhythm Management" includes analysis on the following companies currently active in this market:
Medtronic
Abbott
Boston Scientific
*Not all companies may be currently active in every segment. For more details contact an iData Research Product Advisor.